Geulah Livshits
Stock Analyst at Chardan Capital
(4.16)
# 446
Out of 5,126 analysts
247
Total ratings
45.56%
Success rate
16.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LXEO Lexeo Therapeutics | Maintains: Buy | $17 | $7.16 | +137.43% | 14 | Jan 13, 2026 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $12 | $4.61 | +160.30% | 17 | Jan 6, 2026 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $26 | $8.99 | +189.21% | 14 | Dec 18, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $110 → $174 | $82.20 | +111.68% | 6 | Dec 16, 2025 | |
| TNYA Tenaya Therapeutics | Maintains: Buy | $9 → $8 | $0.81 | +885.83% | 14 | Dec 12, 2025 | |
| SNTI Senti Biosciences | Maintains: Buy | $12 → $13 | $0.93 | +1,297.40% | 11 | Dec 9, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $82 → $74 | $48.74 | +51.83% | 16 | Nov 26, 2025 | |
| IMTX Immatics | Maintains: Buy | $25 | $9.63 | +159.61% | 3 | Nov 24, 2025 | |
| IMRX Immuneering | Maintains: Buy | $20 | $4.93 | +305.68% | 15 | Nov 13, 2025 | |
| PASG Passage Bio | Maintains: Buy | $6 → $21 | $9.51 | +120.82% | 6 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $3.57 | +152.10% | 7 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $26 | $12.28 | +111.73% | 17 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $17 | $2.53 | +571.94% | 15 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $6.52 | +130.06% | 9 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $216 → $220 | $272.74 | -19.34% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $3.16 | +248.10% | 22 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $1.54 | +614.29% | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6 | $1.70 | +252.94% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.82 | - | 10 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $7.43 | +451.82% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.51 | +378.09% | 4 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $191 → $208 | $41.01 | +407.19% | 7 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $0.72 | +2,137.76% | 4 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $10.33 | +771.25% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $4 | $3.68 | +8.70% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $24.88 | -27.65% | 1 | Oct 27, 2020 |
Lexeo Therapeutics
Jan 13, 2026
Maintains: Buy
Price Target: $17
Current: $7.16
Upside: +137.43%
Taysha Gene Therapies
Jan 6, 2026
Maintains: Buy
Price Target: $12
Current: $4.61
Upside: +160.30%
4D Molecular Therapeutics
Dec 18, 2025
Maintains: Buy
Price Target: $26
Current: $8.99
Upside: +189.21%
Palvella Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $110 → $174
Current: $82.20
Upside: +111.68%
Tenaya Therapeutics
Dec 12, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $0.81
Upside: +885.83%
Senti Biosciences
Dec 9, 2025
Maintains: Buy
Price Target: $12 → $13
Current: $0.93
Upside: +1,297.40%
CRISPR Therapeutics AG
Nov 26, 2025
Maintains: Buy
Price Target: $82 → $74
Current: $48.74
Upside: +51.83%
Immatics
Nov 24, 2025
Maintains: Buy
Price Target: $25
Current: $9.63
Upside: +159.61%
Immuneering
Nov 13, 2025
Maintains: Buy
Price Target: $20
Current: $4.93
Upside: +305.68%
Passage Bio
Nov 12, 2025
Maintains: Buy
Price Target: $6 → $21
Current: $9.51
Upside: +120.82%
Nov 10, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $3.57
Upside: +152.10%
Nov 7, 2025
Maintains: Buy
Price Target: $48 → $26
Current: $12.28
Upside: +111.73%
Nov 6, 2025
Maintains: Buy
Price Target: $20 → $17
Current: $2.53
Upside: +571.94%
Nov 4, 2025
Maintains: Buy
Price Target: $15
Current: $6.52
Upside: +130.06%
Nov 4, 2025
Maintains: Buy
Price Target: $216 → $220
Current: $272.74
Upside: -19.34%
Oct 14, 2025
Maintains: Buy
Price Target: $11
Current: $3.16
Upside: +248.10%
Aug 15, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $1.54
Upside: +614.29%
May 16, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $1.70
Upside: +252.94%
Dec 13, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.82
Upside: -
Aug 11, 2023
Reiterates: Buy
Price Target: $41
Current: $7.43
Upside: +451.82%
Mar 22, 2023
Reiterates: Buy
Price Target: $12
Current: $2.51
Upside: +378.09%
Jan 18, 2023
Maintains: Neutral
Price Target: $191 → $208
Current: $41.01
Upside: +407.19%
Nov 15, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $0.72
Upside: +2,137.76%
Nov 3, 2021
Maintains: Buy
Price Target: $100 → $90
Current: $10.33
Upside: +771.25%
Nov 3, 2021
Maintains: Neutral
Price Target: $5.5 → $4
Current: $3.68
Upside: +8.70%
Oct 27, 2020
Initiates: Buy
Price Target: $18
Current: $24.88
Upside: -27.65%